These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 7347699
21. Group A streptococci: evaluation of in vitro resistance to two macrolides. Millesimo M, Savoia D. Microbios; 1995; 82(332):141-7. PubMed ID: 7630322 [Abstract] [Full Text] [Related]
22. Antimicrobial resistance of Staphylococcus aureus and oral streptococci strains from high-risk endocarditis patients. Groppo FC, Castro FM, Pacheco AB, Motta RH, Filho TR, Ramacciato JC, Florio FM, Meechan JG. Gen Dent; 2005; 53(6):410-3. PubMed ID: 16366048 [Abstract] [Full Text] [Related]
23. Failure of two macrolide antibiotics to prevent post-extraction bacteraemia. Cannell H, Kerawala C, Sefton AM, Maskell JP, Seymour A, Sun ZM, Williams JD. Br Dent J; 1991 Sep 21; 171(6):170-3. PubMed ID: 1832916 [Abstract] [Full Text] [Related]
25. [Differentiation of resistance phenotypes among erythromycin-resistant streptococci]. Bejuk D. Acta Med Croatica; 2004 Aug 21; 58(4):301-6. PubMed ID: 15700686 [Abstract] [Full Text] [Related]
26. In vitro combined effect of co-amoxiclav concentrations achievable in serum after a 2000/125 mg oral dose, and polymorphonuclear neutrophils against strains of Streptococcus pneumoniae exhibiting decreased susceptibility to amoxicillin. Amores R, Alou L, Giménez MJ, Sevillano D, Gómez-Lus ML, Aguilar L, Prieto J. Int J Antimicrob Agents; 2004 Jul 21; 24(1):79-82. PubMed ID: 15225866 [Abstract] [Full Text] [Related]
27. [Antibacterial activity of clarithromycin and its hydroxylated derivative and two other macrolides against thirty strains of Streptococcus pneumoniae]. Ploy MC, Mounier M, Denis F. Pathol Biol (Paris); 1994 May 21; 42(5):379-84. PubMed ID: 7824300 [Abstract] [Full Text] [Related]
28. [In vitro comparative activity of five macrolides against 190 Branhamella catarrhalis strains]. Chardon H, Bellon O, Bourgeois F, Lagier E. Pathol Biol (Paris); 1989 May 21; 37(5):382-5. PubMed ID: 2506512 [Abstract] [Full Text] [Related]
29. The in-vitro activity of RP 59500 against gram-positive cocci. Goto S, Miyazaki S, Kaneko Y. J Antimicrob Chemother; 1992 Jul 21; 30 Suppl A():25-8. PubMed ID: 1399947 [Abstract] [Full Text] [Related]
30. [Macrolide resistance phenotypes and genotypes in group G streptococci]. Açikgöz ZC, Göçer S, Almayanlar E. Mikrobiyol Bul; 2003 Jul 21; 37(2-3):117-24. PubMed ID: 14593892 [Abstract] [Full Text] [Related]
31. Beta-lactam activity against penicillin-resistant Streptococcus pneumoniae strains exhibiting higher amoxicillin versus penicillin minimum inhibitory concentration values: an in vitro pharmacodynamic simulation. Sevillano D, Aguilar L, Alou L, Giménez MJ, González N, Echeverría O, Torrico M, Valdes L, Coronel P, Prieto J. Chemotherapy; 2008 Jul 21; 54(2):84-90. PubMed ID: 18303256 [Abstract] [Full Text] [Related]
32. [Sensitivity of group A beta-hemolytic Streptococcus isolated from pediatric pharyngotonsillitis to erythromycin and clarithromycin: a primary care multicenter study]. García de Lomas J, Gimeno C, Díez J, Bermejo M, Navarro D, García-Ponte L. Enferm Infecc Microbiol Clin; 1999 Jan 21; 17(1):24-8. PubMed ID: 10069109 [Abstract] [Full Text] [Related]
33. Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens. Noviello S, Ianniello F, Leone S, Esposito S. J Antimicrob Chemother; 2003 Nov 21; 52(5):869-72. PubMed ID: 14519672 [Abstract] [Full Text] [Related]
34. Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: a phase I, open-label, noncomparative clinical trial in healthy volunteers. Ponte C, Gracia M, Giménez MJ, Aguilar L, Maín CM, Carpintero Y, Huelves L, Carcas A, del Prado G, Soriano F. Clin Ther; 2005 Jul 21; 27(7):1043-9. PubMed ID: 16154483 [Abstract] [Full Text] [Related]
35. [Susceptibility study on urogenital Chlamydia trachomatis to 19 kinds of antibiotics]. Bai H, Dong J, Ning B. Zhonghua Yi Xue Za Zhi; 1995 Jan 21; 75(1):11-4, 60. PubMed ID: 7600311 [Abstract] [Full Text] [Related]
36. In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs. Jones RN, Barry AL, Thornsberry C. Antimicrob Agents Chemother; 1983 Aug 21; 24(2):209-15. PubMed ID: 6638988 [Abstract] [Full Text] [Related]
37. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF). Tazumi A, Maeda Y, Goldsmith CE, Coulter WA, Mason C, Millar BC, McCalmont M, Rendall J, Elborn JS, Matsuda M, Moore JE. J Antimicrob Chemother; 2009 Sep 21; 64(3):501-6. PubMed ID: 19584106 [Abstract] [Full Text] [Related]
38. [Antibiotics susceptibility of Streptococcus and Enterococcus: data of Onerba network]. Vachée A, Varon E, Jouy E, Meunier D, Conseil Scientifique de l'Onerba. Pathol Biol (Paris); 2009 May 21; 57(3):240-4. PubMed ID: 18343047 [Abstract] [Full Text] [Related]
39. Effects of erythromycin, josamycin and spiramycin on rat polymorphonuclear leukocyte chemotaxis. Eyraud A, Descotes J, Lombard JY, Laschi-Loquerie A, Tachon P, Veysseyre C, Evreux JC. Chemotherapy; 1986 May 21; 32(4):379-82. PubMed ID: 3731922 [Abstract] [Full Text] [Related]
40. [Study of macrolide-resistant genes in group C and G streptococci]. Seral C, González V, Castillo J, García C, Rubio MC, Gómez-Lus R. Rev Esp Quimioter; 2000 Jun 21; 13(2):171-5. PubMed ID: 10918090 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]